Topic
EFPIA
4 published works
Inside Privacy
EFPIA Issues Statement on Application of the AI Act in the Medicinal Product Lifecycle
By Dan Cooper, Kristof Van Quathem, Sarah Cowlishaw
On April 22, 2024, the European Federation of Pharmaceutical Industries and Associations (“EFPIA”) issued a statement on the application of the AI Act in the medicinal product lifecycle. The EFPIA…
Inside EU Life Sciences
IFPMA and EFPIA Publish New Joint Guidance Note on Social Media and Digital Channels
By Grant Castle, Raj Gathani, Robin Blaney
On 28 September 2022, the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) and European Federation of Pharmaceutical Industries and Associations (EFPIA) published joint guidelines concerning the use of social…
BioSlice Blog
ATTENTION SOCIAL MEDIA USERS: New IFPMA and EFPIA Guidance on use of social media by industry
By Arnold & Porter, Libby Amos-Stone
The international and European self-regulatory bodies for the research-based pharmaceutical industry (IFPMA, International Federation of Pharmaceutical Manufacturers and Associations and EFPIA, European Federation of Pharmaceutical Industries and Associations) yesterday published…
BioSlice Blog
The new IFPMA Code of Practice
By Ian Dodds-Smith, Silvia Valverde, Keir Heinrich
The International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) has recently published a new version of its Code of Practice that will come into force on January 1, 2019, updating…